Electrophysiological Effects of a Single Intravenous Administration of Ivabradine (S 16257) in Adult Patients with Normal Baseline Electrophysiology

被引:129
作者
A. John Camm
Chu-Pak Lau
机构
[1] St George’s Hospital,The Medical School
[2] Queen Mary Hospital,undefined
关键词
Catheter Ablation; Refractory Period; Ivabradine; Reduce Heart Rate; Radiofrequency Catheter Ablation;
D O I
10.2165/00126839-200304020-00001
中图分类号
学科分类号
摘要
Introduction: Ivabradine is a heart rate-lowering agent that selectively inhibits the pacemaker current, If, in the sinoatrial node. The objective of this study was to evaluate the effects of a single intravenous administration of ivabradine on cardiac electrophysiological parameters in patients with normal baseline electrophysiology. The safety profile of ivabradine was also investigated.
引用
收藏
页码:83 / 89
页数:6
相关论文
共 52 条
  • [1] Kannel WB(1987)Heart rate and cardiovascular mortality: The Framingham Study Am Heart J 113 1489-94
  • [2] Kannel C(1990)Influence of heart rate on mortality after acute myocardial infarction Am J Cardiol 1 547-53
  • [3] Paffenbarger RS(1999)Heart rate as a therapeutic target in heart failure Eur Heart J 1 H64-9
  • [4] Hjalmarson E(1997)Management of stable angina pectoris: recommendations of the Task Force of the European Society of Cardiology Eur Heart J 18 394-413
  • [5] Gilpin J(1998)Beta-blocker treatment in heart failure: role of heart rate reduction Basic Res Cardiol 93 148-55
  • [6] Kjekshus J(1995)Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs J Pharmacol Exp Ther 275 659-66
  • [7] Kjekshus L(1999)Heart rate as a therapeutic target in hypertension Eur Heart J 1 H70-5
  • [8] Gullestad P(1999)Heart rate as a therapeutic target in ischaemic heart disease Eur Heart J 1 H58-63
  • [9] Lechat L(2000)Induction of insulin resistance by beta-blockade but not ACE-inhibition: longterm treatment with atenolol or trandolapril J Hum Hypertens 14 175-80
  • [10] Simon B(1994)Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49 Br J Pharmacol 112 37-42